Time to wake up: No impact of COMT Val158Met gene variation on circadian preferences, arousal regulation and sleep

Chronobiology International

Volumn 33, Issue 7, 2016, Pages 893-905

  Jawinski, Philippe ^a,b   Tegelkamp, Sophie ^a   Sander, Christian ^a,b   Häntzsch, Madlen ^a,c   Huang, Jue ^a   Mauche, Nicole ^a   Scholz, Markus ^a   Spada, Janek ^a,b   Ulke, Christine ^a,b   Burkhardt, Ralph ^a,c   Reif, Andreas ^d   Hegerl, Ulrich ^a,b   Hensch, Tilman ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b German Depression Foundation   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

actigraph; arousal; chronotypes; circadian rhythm; COMT Val158Met; DRD4 Exon III VNTR; rs4680; sleep; VIGALL; vigilance

Indexed keywords

ADULT; AGED; AROUSAL; CIRCADIAN RHYTHM; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; REST; SLEEP; SLEEP STAGE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AROUSAL; CIRCADIAN RHYTHM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REST; SLEEP; SLEEP STAGES; YOUNG ADULT;

EID: 84965079904     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.1080/07420528.2016.1178275     Document Type: Article

References (73)

1. M.Akil, B.S.Kolachana, D.A.Rothmond, T.M.Hyde, D.R.Weinberger, J.E.Kleinman (2003). Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci. 23:2008–13.
2. S.M.Alsaadi, J.H.McAuley, J.M.Hush, D.J.Bartlett, Z.M.McKeough, R.R.Grunstein, et al. (2014). Assessing sleep disturbance in low back pain: The validity of portable instruments. PLoS One. 9:e95824.
3. K.Annerbrink, L.Westberg, S.Nilsson, R.Rosmond, G.Holm, E.Eriksson (2008). Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metab Clin Exp. 57:708–11.
4. M.Arns, J.M.Swanson, L.E.Arnold (2015). ADHD prevalence: Altitude or sunlight? Better understanding the interrelations of dopamine and the circadian system. J Atten Disord. doi:10.1177/1087054715599574
5. K.G.Baron, K.J.Reid, A.S.Kern, P.C.Zee (2011). Role of sleep timing in caloric intake and BMI. Obesity. 19:1374–81.
6. C.W.Berridge, D.M.Devilbiss, M.E.Andrzejewski, A.F.T.Arnsten, Amy FT, A.E.Kelley, B.Schmeichel, et al. (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 60:1111–20.
7. K.E.Bloch, O.D.Schoch, J.N.Zhang, E.W.Russi (1999). German version of the Epworth sleepiness scale. Respiration. 66:440–7.
8. S.Bodenmann, H.Landolt (2010). Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep. 33:1027–35.
9. D.J.Buysse, C.F.Reynolds, T.H.Monk, S.R.Berman, D.J.Kupfer (1989). The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 28:193–213.
10. T.R.Castañeda, P.dePrado, B.MarquezBlanca, D.Prieto, F.Mora (2004). Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: Modulation by light. J Pineal Res. 36:177–85.
11. J.Chen, B.K.Lipska, N.Halim, Q.D.Ma, M.Matsumoto, S.Melhem, et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 75:807–21.
12. J.Cohen (1988). Statistical power analysis for the behavioral sciences. 2nd edition. Hillsdale, N.J.: L. Erlbaum Associates.
13. J.Cohen (1965). Some statistical issues in psychological research. In Wolman BB, ed. Handbook of clinical psychology. New York, NY: McGraw-Hill. pp. 95–121.
14. Y.Dauvilliers, E.Neidhart, M.Billiard, M.Tafti (2002). Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Pharmacogenomics J. 2:65–8.
15. Y.Dauvilliers, E.Neidhart, M.Lecendreux, M.Billiard, M.Tafti (2001). MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry. 6:367–72.
16. C.Degen, J.Zschocke, P.Toro, C.Sattler, H.Wahl, P.Schönknecht, et al. (2015). The COMTp.Val158Met polymorphism and cognitive performance in adult development, healthy aging and mild cognitive impairment. Dementia Geriatric Cognit. Disorders. 41:27–34.
17. R.P.Ebstein, O.Novick, R.Umansky, B.Priel, Y.Osher, D.Blaine, et al. (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet. 12:78–80.
18. W.R.Engels (2009). Exact tests for Hardy-Weinberg proportions. Genetics. 183:1431–41.
19. F.Faul, E.Erdfelder, A.Lang, A.Buchner (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39:175–91.
20. B.Frauscher, B.Högl, S.Maret, E.Wolf, E.Brandauer, G.K.Wenning, et al. (2004). Association of daytime sleepiness with COMT polymorphism in patients with Parkinson disease: A pilot study. Sleep. 27:733–6.
21. J.M.Gatt, K.L.O.Burton, Karen LO, L.M.Williams, P.R.Schofield (2015). Specific and common genes implicated across major mental disorders: A review of meta-analysis studies. J Psychiatr Res. 60:1–13.
22. J.Geissler, M.Romanos, U.Hegerl, T.Hensch (2014). Hyperactivity and sensation seeking as autoregulatory attempts to stabilize brain arousal in ADHD and mania? Attention Deficit Hyperactivity Disorders. 6:159–73.
23. I.R.Gizer, C.Ficks, I.D.Waldman (2009). Candidate gene studies of ADHD: A meta-analytic review. Hum Genet. 126:51–90.
24. D.Glass, A.Viñuela, M.N.Davies, A.Ramasamy, L.Parts, D.Knowles, et al. (2013). Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol. 14:R75.
25. D.J.Gottlieb, K.Hek, T.Chen, N.F.Watson, G.Eiriksdottir, E.M.Byrne, et al. (2015). Novel loci associated with usual sleep duration: The CHARGE consortium genome-wide association study. Mol. Psychiatry. 20:1232–9.
26. B.Griefahn, C.Kunemund, P.Brode, P.Mehnert (2001). Zur Validitat der deutschen Ubersetzung des morningness-eveningness-questionnaires von Horne und Östberg. The validity of a German version of the morningness-eveningness-questionnaire developed by Horne and Östberg. Somnologie. 5:71–80.
27. R.Gruber, N.Grizenko, G.Schwartz, L.Ben Amor, J.Gauthier, R.De Guzman, et al. (2006). Sleep and COMT polymorphism in ADHD children: Preliminary actigraphic data. J Am Acad Child Adolesc Psychiatry. 45:982–9.
28. J.A.Gruner, V.R.Marcy, Y.Lin, D.Bozyczko-Coyne, M.J.Marino, M.Gasior (2009). The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep. 32:1425–38.
29. U.Hegerl, T.Hensch (2014). The vigilance regulation model of affective disorders and ADHD. Neurosci Biobehav Rev. 44:45–57.
30. U.Hegerl, H.Himmerich, B.Engmann, T.Hensch (2010). Mania and attention-deficit/hyperactivity disorder: Common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry. 23:1–7.
31. J.A.Horne, O.Östberg (1976). A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 4:97–110.
32. J.Huang, C.Sander, P.Jawinski, C.Ulke, J.Spada, U.Hegerl, et al. (2015). Test-retest reliability of brain arousal regulation as assessed with VIGALL 2.0. Neuropsychiatr Electrophysiol. 1:263.
33. P.Jawinski, C.Sander, N.Mauche, J.Spada, J.Huang, A.Schmidt, et al. (2015). Brain arousal regulation in carriers of bipolar disorder risk alleles. Neuropsychobiology. 72:65–73.
34. M.W.Johns (1991). A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 14:540–5.
35. E.Kereszturi, Z.Tarnok, E.Bognar, K.Lakatos, L.Farkas, J.Gadoros, et al. (2008). Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet. 147B:1431–5.
36. J.Kim, M.J.Bailey, J.L.Weller, D.Sugden, M.F.Rath, M.Møller, et al. (2010). Thyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4). Mol Cell Endocrinol. 314:128–35.
37. D.Landgraf, M.J.McCarthy, D.K.Welsh (2014). Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep. 16:483.
38. M.Laucht, K.Becker, D.Blomeyer, M.H.Schmidt (2007). Novelty seeking involved in mediating the association between the dopamine D4 receptor gene exon III polymorphism and heavy drinking in male adolescents: Results from a high-risk community sample. Biol Psychiatry. 61:87–92.
39. I.Léna, S.Parrot, O.Deschaux, S.Muffat-Joly, V.Sauvinet, B.Renaud, et al. (2005). Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep—wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res. 81:891–9.
40. J.Li, L.Ji (2005). Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb). 95:221–7.
41. A.E.Locke, B.Kahali, S.I.Berndt, A.E.Justice, T.H.Pers, F.R.Day, et al. (2015). Genetic studies of body mass index yield new insights for obesity biology. Nature. 518:197–206.
42. M.Loeffler, C.Engel, P.Ahnert, D.Alfermann, K.Arelin, R.Baber, et al. (2015). The LIFE-adult-study: Objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health. 15:691.
43. T.Lu, Y.Pan, S.Kao, C.Li, I.Kohane, J.Chan, et al. (2004). Gene regulation and DNA damage in the ageing human brain. Nature. 429:883–91.
44. E.J.Mezick, R.R.Wing, J.M.McCaffery (2014). Associations of self-reported and actigraphy-assessed sleep characteristics with body mass index and waist circumference in adults: Moderation by gender. Sleep Med. 15:64–70.
45. D.Mier, P.Kirsch, A.Meyer-Lindenberg (2010). Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis. Mol Psychiatry. 15:918–27.
46. J.M.Monti, D.Monti (2007). The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev. 11:113–33.
47. Murphy KR, Myors B, Wolach AH. (2014). Statistical power analysis. A simple and general model for traditional and modern hypothesis tests. 4th edition. London, UK: Routledge.
48. S.Nakazawa, K.Nakamichi, H.Imai, J.Ichihara (2015). Effect of dopamine D4 receptor agonists on sleep architecture in rats. Prog Neuropsychopharmacol Biol Psychiatry. 63:6–13.
49. J.N.Oak, J.Oldenhof, H.H.Van Tol (2000). The dopamine D(4) receptor: One decade of research. Eur J Pharmacol. 405:303–27.
50. D.A.Ojeda, C.S.Perea, A.Suárez, C.L.Niño, R.M.Gutiérrez, S.López-León, et al. (2014). Common functional polymorphisms in SLC6A4 and COMT genes are associated with circadian phenotypes in a South American sample. Neurol Sci. 35:41–7.
51. S.Olbrich, M.M.Fischer, C.Sander, U.Hegerl, H.Wirtz, A.Bosse-Henck (2015). Objective markers for sleep propensity: Comparison between the multiple sleep latency test and the vigilance algorithm Leipzig. J Sleep Res. 24:450–7.
52. R.Osaki, H.Imaeda, H.Ban, T.Aomatsu, S.Bamba, T.Tsujikawa, et al. (2011). Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease. Exp Ther Med. 2:783–6.
53. G.Papenberg, M.Lövdén, E.J.Laukka, G.Kalpouzos, L.Keller, C.Graff, et al. (2015). Magnified effects of the COMT gene on white-matter microstructure in very old age. Brain Struct. Funct. 220:2927–38.
54. P.Proitsi, M.K.Lupton, S.J.Reeves, G.Hamilton, N.Archer, B.M.Martin, et al. (2012). Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging. 33:791–803.
55. I.Rissling, B.Frauscher, F.Kronenberg, M.Tafti, K.Stiasny-Kolster, A.Robyr, et al. (2006). Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease. Sleep. 29:108–11.
56. Rosenthal R. (1991). Meta-analytic procedures for social research. 2nd edition. Newbury Park, CA: Sage Publications.
57. Rosenthal R. (1994). Parametric measures of effect size. In Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation, pp. 231–244.
58. Rosenthal R, DiMatteo MR. (2001). Meta-analysis: Recent developments in quantitative methods for literature reviews. Annu Rev Psychol. 52:59–82.
59. A.Salatino-Oliveira, J.P.Genro, C.Zeni, G.V.Polanczyk, R.Chazan, A.P.Guimarães, et al. (2011). Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 70:216–21.
60. C.Sander, T.Hensch, D.A.Wittekind, D.Böttger, U.Hegerl (2015). Assessment of wakefulness and brain arousal regulation in psychiatric research. Neuropsychobiology. 72:195–205.
61. M.M.Sharif, A.S.Bahammam (2013). Sleep estimation using BodyMedia’s SenseWear™ armband in patients with obstructive sleep apnea. Ann Thorac Med. 8:53–7.
62. J.Spada, C.Sander, R.Burkhardt, M.Häntzsch, R.Mergl, M.Scholz, et al. (2014). Genetic association of objective sleep phenotypes with a functional polymorphism in the neuropeptide S receptor gene. PLoS One. 9:e98789.
63. J.Spada, M.Scholz, H.Kirsten, T.Hensch, K.Horn, P.Jawinski, et al. Genome-wide association analysis of actigraphic sleep phenotypes in the LIFE-Adult-Study. J Sleep Res. in press.
64. K.Spiegel, E.Tasali, R.Leproult, E.van Cauter (2009). Effects of poor and short sleep on glucose metabolism and obesity risk. Nature reviews. Endocrinology. 5:253–61.
65. A.Strobel, K.P.Lesch, S.Jatzke, F.Paetzold, B.Brocke (2003). Further evidence for a modulation of Novelty Seeking by DRD4 exon III, 5-HTTLPR, and COMT val/met variants. Mol Psychiatry. 8:371–2.
66. S.S.Tworoger, J.Chubak, E.J.Aiello, Y.Yasui, C.M.Ulrich, F.M.Farin, et al. (2004). The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res. 12:972–81.
67. D.Vallone, R.Picetti, E.Borrelli (2000). Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24:125–32.
68. A.Valomon, S.C.Holst, V.Bachmann, A.U.Viola, C.Schmidt, J.Zürcher, et al. (2014). Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults. Chronobiol Int. 31:705–14.
69. J.F.van den Berg, A.Knvistingh Neven, J.H.M.Tulen, A.Hofman, J.C.M.Witteman, H.M.E.Miedema, et al. (2008). Actigraphic sleep duration and fragmentation are related to obesity in the elderly: The Rotterdam Study. Int J Obesity (2005). 32:1083–90.
70. R.S.Waples (2015). Testing for Hardy-Weinberg proportions: Have we lost the plot? J Hered. 106:1–19.
71. J.P.Wisor, S.Nishino, I.Sora, G.H.Uhl, E.Mignot, D.M.Edgar (2001). Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 21:1787–94.
72. K.Wulff, S.Gatti, J.G.Wettstein, R.G.Foster (2010). Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 11:589–99.
73. I.Yujnovsky, J.Hirayama, M.Doi, E.Borrelli, P.Sassone-Corsi (2006). Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. Proc Natl Acad Sci USA. 103:6386–91.